CD44 and breast carcinoma: In primary mammary carcinomas hypoxia increases the proportion of CD44+CD24−/lowESA+ CSCs in tumors that have low levels or no active ER signaling [8, 9], according to their ER and PR expression levels detected by immunohistochemistry.